Your Messages Inbox
Your Article Summary
See Latest ArticlesLicensed Vaccines for Rotavirus Prevention in the US: A Review
Journal of Pharmacy Technology, 10/08/09
Hale LS et al. – RotaTeq and RotaRix are effective for the prevention of rotavirus infection in the US, Europe, and Latin America. Additional studies are needed to assess their duration of protection, worldwide efficacy, effect on the reduction of healthcare resource utilization, and adverse event monitoring.
Related Articles
Secular Variation in United States Rotavirus Disease Rates and Serotypes: Implications for Assessing the Rotavirus Vaccination Program
The Pediatric Infectious Disease Journal, 10/05/09
Relevance Score: 71%
Adoption of Rotavirus Vaccination by Pediatricians and Family Medicine Physicians in the United States
Pediatrics, 10/28/09
Relevance Score: 69%
Intussusception and rotavirus vaccination: a review of the available evidence
Expert Review of Vaccines, 11/02/09
Relevance Score: 68%
Hospital-based study of the severity and economic burden associated with rotavirus diarrhea in Sri Lanka
Journal of Pediatric Infectious Diseases, 11/02/09
Relevance Score: 67%
Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
British Medical Journal, 10/08/09
Relevance Score: 66%
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Article Search
Sponsor